Colorectal cancer is the second-leading cause of cancer deaths, affecting both men and women nearly equally and is one of the most preventable cancers. The American Gastroenterological Association (AGA) Institute supports clinically proven technologies that increase the number of patients screened for colon cancer.

Colorectal cancer is one of the deadliest but most preventable causes of death in the United States. The American Gastroenterological Association (AGA) Institute supports clinically proven technologies that increase the number of patients who are screened for the disease.

Two studies in the October issue of the journal Gastroenterology may help in refining recommendations for the use of colonoscopy to screen for colorectal cancer.

One of the best ways to encourage an individual to get screened for colorectal cancer is to use a personalized approach, according to researchers at Jefferson Medical College in Philadelphia. A new study shows that simple, personalized interventions that guide recipients through the screening process can significantly improve colorectal cancer screening rates in primary care practices.

Different types of personalized interventions can improve colorectal cancer (CRC) screening rates in primary care practices, according to a new study.

Recognizing that CT colonography will play a role in screening for colorectal cancer (CRC), and the critical need to increase overall CRC screening rates, the American Gastroenterological Association (AGA) Institute issued minimum standards for gastroenterologist performance of the test. To ensure competence, a minimum of 75 endoscopically confirmed cases should be interpreted by the physician.

Colorectal cancer is one of the most prevalent cancers in the Western world. The tumor starts off as a polyp but then turns into an invasive and violent cancer, which often spreads to the liver. In an article recently published in the journal Cancer Research, Prof. Avri Ben-Ze’ev and Dr. Nancy Gavert of the Weizmann Institute’s Molecular Cell Biology Department reveal mechanisms that help this cancer metastasize.

600,000 cases a year of breast and colorectal cancer could be prevented each year by adequate intake of vitamin D, according to researcher

Contrary to expectations, diets high in the nutrient choline were associated with an increased risk of some colorectal polyps, which can—but do not always—lead to colorectal cancer, according to a study published online in the August 7 Journal of the National Cancer Institute.

Working with human colorectal cancer cells, a University of Minnesota team, led by cancer biologists Zigang Dong and Ann Bode, has found the potential culprit among a network of enzymes that relay signals inside cells to regulate such functions as cell growth, cancer development and programmed cell death.

A study of Medicare patients with osteoarthritis provides additional evidence that non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin reduce the risk of colorectal cancer.

Since the institution of nationwide folic acid fortification of enriched grains in the mid 1990s, the number of infants born in the United States and Canada with neural tube defects has declined by 20 percent to 50 percent. Concurrent with the institution of fortification, however, the rate at which new cases of colorectal cancer were diagnosed in men and women increased, report researchers at the Jean Mayer USDA Human Nutrition Research Center on Aging (USDA HNRCA) at Tufts University.